Načítá se...
Whole genome sequencing of breast cancer
Breast cancer was the first to take advantage of targeted therapy using endocrine therapy, and for up to 20% of all breast cancer patients a further significant improvement has been obtained by HER2‐targeted therapy. Greater insight in precision medicine is to some extent driven by technical and com...
Uloženo v:
| Vydáno v: | APMIS |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6850492/ https://ncbi.nlm.nih.gov/pubmed/30689231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apm.12920 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|